Albertsons Companies (NYSE:ACI) Bolsa

ALBERTSONS COS INC - CLASS A

Albertsons Companies

Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.

Albertsons Companies, Inc. Class A Common Stock

Albertsons Companies Inc

American Coastal Insurance Corporation - Common Stock

American Coastal Insurance Corp

Aptus Collared Investment Opportunity ETF

AIMS APAC REIT Units Real Estate Investment Trust

AIMS APAC REIT

ASIAN CITRUS HLDGS NEW by Asian Citrus Holdings Ltd.

Asian Citrus Holdings Ltd

ASIAN CITRUS HLDGS LTD by Asian Citrus Holdings Ltd.

AC Immune SA

ACI Worldwide Inc

Acarix AB

<a href="https://teamster.org/2025/06/albertsons-teamsters-ratify-strong-contract-avert-strike/">https://teamster.org/2025/06/albertsons-teamsters-ratify-strong-contract-avert-strike/</a>

News

General

Reported On June 10, 2025 "Albertsons Teamsters Ratify Strong Contract, Avert Strike" -Teamsters

<ul class="wp-block-list">
<li>Walgreens has plans to expand its use of robot-powered micro-fulfillment centers</li>
<li>The centers currently serve 4,800 stores, and fill more than 16 million prescriptions each month</li>
<li>The push for automation comes as Walgreens prepares to go private in a deal with Sycamore Partners</li>
</ul>
Walgreens will be expanding its use of prescription-filling robots, <a href="https://www.cnbc.com/2025/05/11/walgreens-doubles-down-on-robots-to-fill-prescriptions-amid-turnaround.html">CNBC</a> reports.
The pharmacy chain began using micro-fulfillment centers in 2021 before pausing the program in 2023 to focus on feedback and improvement. Now, it&#8217;s working to add more in order to free up time for pharmacy staff, reduce time spent on routine tasks, and eliminate inventory waste.
The robot-powered centers fill thousands of prescriptions for patients who use medication to manage conditions like diabetes and high blood pressure. With those tasks automated, Walgreens told CNBC its pharmacy staff will have more time to interact directly with patients and perform clinical services like vaccinations and testing.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
The company told CNBC it hopes to have 11 micro-fulfillment centers serving 5,000 locations by the end of the year. In February, there were 4,800 stores that utilized the micro-fulfillment centers. On average, these centers handled 40% of the prescription volume at the individual locations, Walgreens says, which translates to about 16 million prescriptions filled each month across all serviced stores.
Kayla Heffington, Walgreens' pharmacy operating model vice president, told CNBC that the company's investment in automation is already paying off. The micro-fulfillment centers have generated $500 million in savings through their increased efficiency and reduction of excess inventory. Stores that use the centers are also administering 40% more vaccines than those that aren't, increasing profits.
"Right now, [the micro-fulfillment centers] are the backbone to really help us offset some of the workload in our stores, to obviously allow more time for our pharmacists and technicians to spend time with patients," Rick Gates, Walgreens' chief pharmacy officer, told CNBC. "It gives us a lot more flexibility to bring down costs, to increase the care and increase speed to therapy – all those things."
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
Gates added that he sees the micro-fulfillment centers as a competitive advantage for Walgreens, because many independent pharmacies and larger rivals don't have the centralized support. However, many of Walgreens' major competitors, like Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>), and Albertsons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>), already have, or are testing, their own versions of the micro-fulfilment facilities.&nbsp;
There are, of course, risks that come with using these micro-fulfillment centers, like a reliance on sophisticated robotics that can cause major disruptions if errors occur. But for Walgreens, the rewards heavily outweigh the risks.
Heffington told CNBC that the automated locations have helped reduce prescription fulfillment costs by nearly 13% year over year, and have increased prescription volume by 126%. The centers also allow the company to have real-time data on all prescription fulfillments, enabling its employees to provide better customer service.&nbsp;
The renewed push for automation comes as Walgreens prepares to go private in a <a href="https://investor.walgreensbootsalliance.com/news-releases/news-release-details/walgreens-boots-alliance-enters-definitive-agreement-be-acquired">$10 billion deal with Sycamore Partners</a>. The buyout is expected to be complete by the end of the year.&nbsp;
Read Next:
<ul class="wp-block-list">
<li>The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
</ul>
Image: Shutterstock

Personal Finance

Walgreens To Expand Use Of Prescription-Filling Robots, Cites $500 Million In Savings As Motive

https://teamster.org/2025/05/teamsters-at-albertsons-vote-overwhelmingly-to-authorize-strike/#:~:text=More%20Than%2090%20Drivers%20Demand,and%20Protections%20Against%20Autonomous%20Trucks&amp;text=(DALLAS)%20%E2%80%93%20Over%2090%20drivers,to%20offer%20a%20fair%20contract.

'Teamsters At Albertsons Vote Overwhelmingly To Authorize Strike; More Than 90 Drivers Demand Fair Pay, Strong Benefits, and Protections Against Autonomous Trucks' - Teamsters

Federal health officials have linked a listeria outbreak that hospitalized 10 people to a California-based food producer, prompting a voluntary recall of ready-to-eat products across four western states.
What Happened: The U.S. Food and Drug Administration announced Saturday that San Fernando-based Fresh &amp; Ready Foods LLC has been identified as the source of contamination that sickened people in California and Nevada, <a href="https://apnews.com/article/listeria-outbreak-food-sick-c11ddb49f357f227797fe42c468115f5">reported</a> the Associated Press. 
The investigation initially began last year but was reopened in April when FDA investigators found listeria in samples collected from Fresh &amp; Ready Foods that matched the strain from the outbreak. 
The contaminated products were distributed to retailers and food service points of sale, including hospitals, hotels, convenience stores, airports and by airlines in Arizona, California, Nevada and Washington, according to the FDA. 
Fresh &amp; Ready Foods has voluntarily recalled several products with &#8220;use by&#8221; dates from April 22 to May 19 under multiple brand names: Fresh &amp; Ready Foods, City Point Market Fresh Food to Go and Fresh Take Crave Away.
See Also: <a href="https://www.benzinga.com/markets/25/05/45342977/trumps-tariffs-reportedly-push-walmart-and-target-toy-suppliers-to-the-brink-of-closure-if-nothing-changes-well-be-crippled">Trump&#8217;s Tariffs Reportedly Push Walmart And Target Toy Suppliers To The Brink Of Closure: &#8216;If Nothing Changes, We&#8217;ll Be Crippled&#8217;</a>
Why It Matters: Fresh &amp; Ready Foods said in a news release that it took immediate corrective actions, including removing equipment to address the issue, AP report noted. 
The Centers for Disease Control and Prevention noted that test samples from sick patients were collected between December 2023 and September 2024, with six of the 10 affected individuals having been hospitalized before contracting listeria.
This outbreak follows a similar recall by Albertsons Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) which voluntarily recalled 12 types of ReadyMeals and deli items supplied by Fresh Creative Foods due to <a href="https://www.benzinga.com/markets/equities/24/10/41310010/listeria-scare-prompts-albertsons-to-recall-certain-ready-to-eat-meals-in-multiple-states?utm_source=chatgpt.com">potential contamination with Listeria monocytogenes</a>. 
That recall was <a href="https://www.benzinga.com/markets/equities/24/10/41310010/listeria-scare-prompts-albertsons-to-recall-certain-ready-to-eat-meals-in-multiple-states?utm_source=chatgpt.com">triggered after routine tests</a> by the U.S. Department of Agriculture&#8217;s Food Safety and Inspection Service (FSIS) detected contamination in a ready-to-eat chicken ingredient from BrucePac in Durant, Oklahoma. 
The recalled items were sold across several major retail chains including Albertsons, Safeway, Jewel-Osco, Vons, and stores across several states, including California, Texas, Illinois, and Washington.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/05/45342962/bill-gates-slams-trumps-tariffs-we-told-china-to-make-their-own-chips-and-theyre-making-great-progress-warns-its-a-bad-time-to-inte">Bill Gates Slams Trump&#8217;s Tariffs: We Told China To &#8216;Make Their Own Chips&#8217; —And &#8216;They&#8217;re Making Great Progress,&#8217; Warns It&#8217;s A &#8216;Bad Time To Interject So Much Uncertainty&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Regulations

Health Care

Listeria Outbreak Linked To California's Fresh & Ready Foods Prompts Recall Across 4 States — 10 Hospitalized As FDA, CDC Investigate Contamination

BMO Capital analyst Kelly Bania upgrades Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) from Market Perform to Outperform and raises the price target from $19 to $25.

Upgrades

Price Target

Analyst Ratings

BMO Capital Upgrades Albertsons Companies to Outperform, Raises Price Target to $25

JP Morgan analyst Ken Goldman maintains Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Overweight and raises the price target from $24 to $31.

JP Morgan Maintains Overweight on Albertsons Companies, Raises Price Target to $31

Management

Susan Morris Named CEO of Albertsons Companies Effective May 1

In the last three months, 12 analysts have published ratings on Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $24.25, with a high estimate of $28.00 and a low estimate of $22.00. This current average represents a 0.08% decrease from the previous average price target of $24.27. 
<img src="https://www.benzinga.com/files/images/story/2025/1745503260_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Albertsons Companies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;---------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ivan Feinseth &#x7C;Tigress Financial &#x7C;Raises &#x7C;Buy &#x7C; $28.00&#x7C;$27.00 &#x7C; 
&#x7C;Michael Montani &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;In-Line &#x7C; $22.00&#x7C;$23.00 &#x7C; 
&#x7C;Steven Shemesh &#x7C;RBC Capital &#x7C;Maintains &#x7C;Outperform &#x7C; $23.00&#x7C;$23.00 &#x7C; 
&#x7C;Mark Carden &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $22.00&#x7C;$24.00 &#x7C; 
&#x7C;Joe Feldman &#x7C;Telsey Advisory Group&#x7C;Lowers &#x7C;Outperform &#x7C; $24.00&#x7C;$26.00 &#x7C; 
&#x7C;Joe Feldman &#x7C;Telsey Advisory Group&#x7C;Maintains &#x7C;Outperform &#x7C; $26.00&#x7C;$26.00 &#x7C; 
&#x7C;Steven Shemesh &#x7C;RBC Capital &#x7C;Maintains &#x7C;Outperform &#x7C; $23.00&#x7C;$23.00 &#x7C; 
&#x7C;Steven Shemesh &#x7C;RBC Capital &#x7C;Raises &#x7C;Outperform &#x7C; $23.00&#x7C;$22.00 &#x7C; 
&#x7C;Michael Montani &#x7C;Evercore ISI Group &#x7C;Raises &#x7C;In-Line &#x7C; $22.00&#x7C;$21.00 &#x7C; 
&#x7C;Joe Feldman &#x7C;Telsey Advisory Group&#x7C;Maintains &#x7C;Outperform &#x7C; $26.00&#x7C;$26.00 &#x7C; 
&#x7C;Joe Feldman &#x7C;Telsey Advisory Group&#x7C;Maintains &#x7C;Outperform &#x7C; $26.00&#x7C;$26.00 &#x7C; 
&#x7C;Leah Jordan &#x7C;Goldman Sachs &#x7C;Announces &#x7C;Buy &#x7C; $26.00&#x7C;- &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Albertsons Companies. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Albertsons Companies compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Albertsons Companies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Albertsons Companies's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ACI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Albertsons Companies analyst ratings.</a>
<h2>All You Need to Know About Albertsons Companies</h2>
Albertsons is the second largest supermarket operator in the United States with more than 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.
<h3>Albertsons Companies: Delving into Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Albertsons Companies's remarkable performance in 3M is evident. As of 28 February, 2025, the company achieved an impressive revenue growth rate of 2.51%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Albertsons Companies's net margin is impressive, surpassing industry averages. With a net margin of 0.91%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Albertsons Companies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.09%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Albertsons Companies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.64% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 4.19, Albertsons Companies faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Albertsons Companies In The Eyes Of 12 Experts

Tigress Financial analyst Ivan Feinseth maintains Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Buy and raises the price target from $27 to $28.

Tigress Financial Maintains Buy on Albertsons Companies, Raises Price Target to $28

Evercore ISI Group analyst Michael Montani maintains Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a In-Line and lowers the price target from $23 to $22.

Evercore ISI Group Maintains In-Line on Albertsons Companies, Lowers Price Target to $22

WIIM

Albertsons Companies shares are trading higher on possible continued strength after the company reported better-than-expected Q4 financial results yesterday. RBC Capital and Telsey Advisory Group reiterated Outperform ratings on the stock.

RBC Capital analyst Steven Shemesh reiterates Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Outperform and maintains $23 price target.

Reiteration

RBC Capital Reiterates Outperform on Albertsons Companies, Maintains $23 Price Target

UBS analyst Mark Carden maintains Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Neutral and lowers the price target from $24 to $22.

UBS Maintains Neutral on Albertsons Companies, Lowers Price Target to $22

Telsey Advisory Group analyst Joe Feldman maintains Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Outperform and lowers the price target from $26 to $24.

Telsey Advisory Group Maintains Outperform on Albertsons Companies, Lowers Price Target to $24

Albertsons Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) shares are <a href="https://www.benzinga.com/premarket">trading lower in premarket </a>on Tuesday after the fourth-quarter earnings result.
The company reported <a href="https://www.benzinga.com/pressreleases/25/04/b44809649/albertsons-companies-inc-reports-fourth-quarter-and-full-year-results">fourth-quarter FY24 sales growth of 2.5%</a> year-on-year to $18.8 billion, beating the analyst consensus estimate of $18.79 billion.
The increase was driven by 2.3% increase in identical sales, with strong growth in pharmacy sales being the primary driver of the identical sales increase.&nbsp;Digital sales improved 24%.
Gross margin rate contracted 60 basis points to 27.4%. The operating margin was 1.5%, and operating income for the quarter declined 35% to $276 million.
Adjusted EBITDA of $855.1 million decreased 6.6% Y/Y. Adjusted EPS of 46 cents <a href="https://www.benzinga.com/earnings">beat the consensus estimate </a>of 40 cents.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44800444/goldman-sachs-cuts-outlook-for-these-hotel-and-lodging-stocks-as-potential-recession-looms">Goldman Sachs Cuts Outlook For These Hotel And Lodging Stocks As Potential Recession Looms</a>
The grocery store giant held $293.6 million in cash and equivalents as of Feb. 22. Operating cash flow for 12 months totaled $2.68 billion.
Today, it announced the next quarterly dividend payment of 15 cents per share to be paid on May 9 to stockholders of record as of the close of business on April 25, 2025.
In the fourth-quarter, Albertsons repurchased an aggregate of 4.1 million shares of common stock for a total of $82.5 million.
Total&nbsp;debt, including finance leases, was $7.84 billion for the fiscal 2024. Net debt ratio was 1.88.
Albertsons CEO Vivek Sankaran highlighted continued investment in the company&#8217;s &#8220;Customers for Life&#8221; strategy.
Outlook: Albertsons&nbsp;anticipates FY25 adjusted EPS of $2.03 – 2.16 versus an estimate of $2.28.
ACI expects FY25 identical sales growth of 1.5% – 2.5%.&nbsp;
The Boise, Idaho-based company expects FY25 capital expenditures of $1.7 billion to $1.9 billion.
Price Action: ACI shares traded lower by 6.12% at $20.25 at last check Tuesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44799936/nvidia-to-build-500b-ai-infrastructure-in-us-in-the-next-four-years-details">Nvidia To Build $500 Billion AI Infrastructure In US In the Next Four Years</a></li>
</ul>
Image: Shutterstock

Why Is Grocery Giant Albertsons' Stock Price Shrinking Today?

Albertsons Companies shares are trading lower after the company issued FY26 adjusted EPS guidance below the estimate.

Albertsons Posts Q4 Identical Sales Increase Of 2.3%

Guidance

Albertsons Sees FY25 Adj EPS Of $2.03 - $2.16 Vs. $2.28 Est.

Albertsons Sees FY25 Identical Sales Growth Of 1.5% - 2.5%

Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.40 by 15 percent. This is a 14.81 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $18.80 billion which beat the analyst consensus estimate of $18.79 billion by 0.05 percent. This is a 2.51 percent increase over sales of $18.34 billion the same period last year.

Earnings

Earnings Beats

Albertsons Companies Q4 Adj $0.46 Beats $0.40 Estimate, Sales $18.80B Beat $18.79B Estimate

Press Releases

Albertsons® Companies Announces New Goal to Enable 1.5 Billion Meals Across Local Communities by 2030

Albertsons Companies Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call Date

Albertsons® Companies Launches Over 20 Limited Edition Own Brands Products to Celebrate the Spring Season

Albertsons Companies Announces Common Stock Dividend

Albertsons Companies, Inc. Reports Fourth Quarter and Full Year Results

Albertsons® Companies Simplifies Mother's Day Shopping with Convenient Gift and Delivery Options

Kimco Realty® Announces First Quarter 2025 Results

Albertsons® Companies Expands Business eCommerce Platform

Albertsons® Companies Launches New Own Brand, Chef's Counter™, an Innovative Chef-Inspired Meal Solution for Foodies Craving New Flavors and Inspiration

Albertsons® Companies Pharmacies Welcomes Rite Aid Customers and Employees

Caseys General Stores, Inc. - Common Stock

Casey's General Stores

Chanson International Holding - Class A Ordinary Shares

Chanson International

Dingdong (Cayman) Limited American Depositary Shares (each two representing three Ordinary Shares)

Comments

Albertsons Companies

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL